Antoine Magnan
Antoine Magnan
Verifierad e-postadress på
Citeras av
Citeras av
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
F Lavorini, A Magnan, JC Dubus, T Voshaar, L Corbetta, M Broeders, ...
Respiratory medicine 102 (4), 593-604, 2008
The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team
GK Crompton, PJ Barnes, M Broeders, C Corrigan, L Corbetta, ...
Respiratory medicine 100 (9), 1479-1494, 2006
Importance of inhaler devices in the management of airway disease
JC Virchow, GK Crompton, R Dal Negro, S Pedersen, A Magnan, ...
Respiratory medicine 102 (1), 10-19, 2008
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients
M Humbert, G Monti, M Fartoukh, A Magnan, F Brenot, B Rain, F Capron, ...
European Respiratory Journal 11 (3), 554-559, 1998
Assessment of the Th1/Th2 Paradigm in Whole Blood in Atopy and Asthma: Increased IFN- γ –producing CD8+ T Cells in Asthma
AO Magnan, LG Mely, CA Camilla, MM Badier, FA Montero-Julian, ...
American journal of respiratory and critical care medicine 161 (6), 1790-1796, 2000
Allergic vs nonallergic asthma: what makes the difference?
S Romanet‐Manent, D Charpin, A Magnan, A Lanteaume, D Vervloet, ...
Allergy 57 (7), 607-613, 2002
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind …
GL Chupp, ES Bradford, FC Albers, DJ Bratton, J Wang-Jairaj, LM Nelsen, ...
The Lancet Respiratory Medicine 5 (5), 390-400, 2017
IL-17 in severe asthma. Where do we stand?
J Chesné, F Braza, G Mahay, S Brouard, M Aronica, A Magnan
American journal of respiratory and critical care medicine 190 (10), 1094-1101, 2014
Cellular interactions in the pathogenesis of interstitial lung diseases
G Bagnato, S Harari
European Respiratory Review 24 (135), 102-114, 2015
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ...
Allergy 70 (11), 1372-1392, 2015
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma
G Garcia, A Magnan, R Chiron, C Contin-Bordes, P Berger, C Taillé, ...
Chest 144 (2), 411-419, 2013
Research needs in allergy: an EAACI position paper, in collaboration with EFA
NG Papadopoulos, I Agache, S Bavbek, BM Bilo, F Braido, V Cardona, ...
Clinical and translational allergy 2 (1), 1-23, 2012
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ...
Clinical and translational allergy 6 (1), 1-14, 2016
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ...
Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy
A Pipet, K Botturi, D Pinot, D Vervloet, A Magnan
Respiratory medicine 103 (6), 800-812, 2009
Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross‐sectional study
A Magnan, JP Meunier, C Saugnac, J Gasteau, F Neukirch
Allergy 63 (3), 292-298, 2008
Masitinib, ac‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics
M Humbert, F De Blay, G Garcia, A Prud’homme, C Leroyer, A Magnan, ...
Allergy 64 (8), 1194-1201, 2009
EAACI position statement on asthma exacerbations and severe asthma
A Custovic, SL Johnston, I Pavord, M Gaga, L Fabbri, EH Bel, P Le Souëf, ...
Allergy 68 (12), 1520-1531, 2013
Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy
C Pinet, A Magnan, L Garbe, MJ Payan, D Vervloet
European Respiratory Journal 14 (1), 237-238, 1999
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
M Pain, O Bermudez, P Lacoste, PJ Royer, K Botturi, A Tissot, S Brouard, ...
European Respiratory Review 23 (131), 118-130, 2014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20